ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eptacog Alfa (rFVIIa) Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-2V11068
Home | Market Reports | Health| Health Conditions
Global Eptacog Alfa rFVIIa Market Research Report 2022
BUY CHAPTERS

Global Eptacog Alfa (rFVIIa) Market Research Report 2025

Code: QYRE-Auto-2V11068
Report
March 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
LFB SA
Generium
CSL Limited
Shire (Takeda)
Bayer
Northland-bio
Novo Nordisk

Eptacog Alfa (rFVIIa) Market Size

The global market for Eptacog Alfa (rFVIIa) was valued at US$ 1315 million in the year 2024 and is projected to reach a revised size of US$ 1794 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Eptacog Alfa (rFVIIa) Market

Eptacog Alfa (rFVIIa) Market

Recombinant human coagulation factor VIIa is a drug from Novo Nordisk for bleeding episodes and prevention of bleeding during surgical procedures or invasive procedures in the following patient groups:
1. Inhibitors of coagulation factor VIII or IX 5BU in congenital hemophilia patients; 2. Congenital hemophilia patients who are expected to have a high memory response to injection of coagulation factor VIII or coagulation factor IX; 3. Acquired blood 4. Patients with congenital FVII deficiency; 5. Patients with thrombocytopenia who have GP IIb-IIIa and/or HLA antibodies and past or present ineffective or poor platelet transfusions.
Novo Nordisk is the largest manufacturers of eptacog alfa (rFVIIa) in the world, has a share about 92%. Other players include LFB SA, GENERIUM,Northland-bio, and Northland-bioi, etc. The key players are mainly located in Europe, North America, China, and Japan. In terms of product, freeze-dried preparation is the largest segment, with a share over 52%. And in terms of application, the largest application is hemophilia, with a share over 48%, followed by acquired hemophilia.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Eptacog Alfa (rFVIIa), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eptacog Alfa (rFVIIa).
The Eptacog Alfa (rFVIIa) market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eptacog Alfa (rFVIIa) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eptacog Alfa (rFVIIa) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Eptacog Alfa (rFVIIa) Market Report

Report Metric Details
Report Name Eptacog Alfa (rFVIIa) Market
Accounted market size in year US$ 1315 million
Forecasted market size in 2031 US$ 1794 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Freeze-dried Preparation
  • Freeze-dried Powder
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, LFB SA, GENERIUM, Northland-bio, CSL, Shire (Takeda), Bayer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Eptacog Alfa (rFVIIa) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Eptacog Alfa (rFVIIa) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Eptacog Alfa (rFVIIa) Market growing?

Ans: The Eptacog Alfa (rFVIIa) Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Eptacog Alfa (rFVIIa) Market size in 2031?

Ans: The Eptacog Alfa (rFVIIa) Market size in 2031 will be US$ 1794 million.

What is the Novo Nordisk share in Eptacog Alfa (rFVIIa) Market?

Ans: Novo Nordisk is the largest manufacturers of eptacog alfa (rFVIIa) in the world, has a share about 92%.

What is the Eptacog Alfa (rFVIIa) Market share by type?

Ans: In terms of product, freeze-dried preparation is the largest segment, with a share over 52%.

Who are the main players in the Eptacog Alfa (rFVIIa) Market report?

Ans: The main players in the Eptacog Alfa (rFVIIa) Market are Novo Nordisk, LFB SA, GENERIUM, Northland-bio, CSL, Shire (Takeda), Bayer

What are the Application segmentation covered in the Eptacog Alfa (rFVIIa) Market report?

Ans: The Applications covered in the Eptacog Alfa (rFVIIa) Market report are Hemophilia, Acquired Hemophilia, Factor VII Deficiency, Glanzmann Thrombasthenia (GT)

What are the Type segmentation covered in the Eptacog Alfa (rFVIIa) Market report?

Ans: The Types covered in the Eptacog Alfa (rFVIIa) Market report are Freeze-dried Preparation, Freeze-dried Powder

Recommended Reports

Coagulation Diagnostics

Hemophilia Treatments

Anticoagulant Medicines

1 Eptacog Alfa (rFVIIa) Market Overview
1.1 Product Definition
1.2 Eptacog Alfa (rFVIIa) by Type
1.2.1 Global Eptacog Alfa (rFVIIa) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Freeze-dried Preparation
1.2.3 Freeze-dried Powder
1.3 Eptacog Alfa (rFVIIa) by Application
1.3.1 Global Eptacog Alfa (rFVIIa) Market Value by Application (2024 VS 2031)
1.3.2 Hemophilia
1.3.3 Acquired Hemophilia
1.3.4 Factor VII Deficiency
1.3.5 Glanzmann Thrombasthenia (GT)
1.4 Global Eptacog Alfa (rFVIIa) Market Size Estimates and Forecasts
1.4.1 Global Eptacog Alfa (rFVIIa) Revenue 2020-2031
1.4.2 Global Eptacog Alfa (rFVIIa) Sales 2020-2031
1.4.3 Global Eptacog Alfa (rFVIIa) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Eptacog Alfa (rFVIIa) Market Competition by Manufacturers
2.1 Global Eptacog Alfa (rFVIIa) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Eptacog Alfa (rFVIIa) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Eptacog Alfa (rFVIIa) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Eptacog Alfa (rFVIIa), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eptacog Alfa (rFVIIa), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eptacog Alfa (rFVIIa), Product Type & Application
2.7 Global Key Manufacturers of Eptacog Alfa (rFVIIa), Date of Enter into This Industry
2.8 Global Eptacog Alfa (rFVIIa) Market Competitive Situation and Trends
2.8.1 Global Eptacog Alfa (rFVIIa) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Eptacog Alfa (rFVIIa) Players Market Share by Revenue
2.8.3 Global Eptacog Alfa (rFVIIa) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Eptacog Alfa (rFVIIa) Market Scenario by Region
3.1 Global Eptacog Alfa (rFVIIa) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Eptacog Alfa (rFVIIa) Sales by Region: 2020-2031
3.2.1 Global Eptacog Alfa (rFVIIa) Sales by Region: 2020-2025
3.2.2 Global Eptacog Alfa (rFVIIa) Sales by Region: 2026-2031
3.3 Global Eptacog Alfa (rFVIIa) Revenue by Region: 2020-2031
3.3.1 Global Eptacog Alfa (rFVIIa) Revenue by Region: 2020-2025
3.3.2 Global Eptacog Alfa (rFVIIa) Revenue by Region: 2026-2031
3.4 North America Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.4.1 North America Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.4.3 North America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.5.1 Europe Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.5.3 Europe Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eptacog Alfa (rFVIIa) Market Facts & Figures by Region
3.6.1 Asia Pacific Eptacog Alfa (rFVIIa) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Eptacog Alfa (rFVIIa) Sales by Region (2020-2031)
3.6.3 Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.7.1 Latin America Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.7.3 Latin America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.8.1 Middle East and Africa Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eptacog Alfa (rFVIIa) Sales by Type (2020-2031)
4.1.1 Global Eptacog Alfa (rFVIIa) Sales by Type (2020-2025)
4.1.2 Global Eptacog Alfa (rFVIIa) Sales by Type (2026-2031)
4.1.3 Global Eptacog Alfa (rFVIIa) Sales Market Share by Type (2020-2031)
4.2 Global Eptacog Alfa (rFVIIa) Revenue by Type (2020-2031)
4.2.1 Global Eptacog Alfa (rFVIIa) Revenue by Type (2020-2025)
4.2.2 Global Eptacog Alfa (rFVIIa) Revenue by Type (2026-2031)
4.2.3 Global Eptacog Alfa (rFVIIa) Revenue Market Share by Type (2020-2031)
4.3 Global Eptacog Alfa (rFVIIa) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Eptacog Alfa (rFVIIa) Sales by Application (2020-2031)
5.1.1 Global Eptacog Alfa (rFVIIa) Sales by Application (2020-2025)
5.1.2 Global Eptacog Alfa (rFVIIa) Sales by Application (2026-2031)
5.1.3 Global Eptacog Alfa (rFVIIa) Sales Market Share by Application (2020-2031)
5.2 Global Eptacog Alfa (rFVIIa) Revenue by Application (2020-2031)
5.2.1 Global Eptacog Alfa (rFVIIa) Revenue by Application (2020-2025)
5.2.2 Global Eptacog Alfa (rFVIIa) Revenue by Application (2026-2031)
5.2.3 Global Eptacog Alfa (rFVIIa) Revenue Market Share by Application (2020-2031)
5.3 Global Eptacog Alfa (rFVIIa) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Eptacog Alfa (rFVIIa) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 LFB SA
6.2.1 LFB SA Company Information
6.2.2 LFB SA Description and Business Overview
6.2.3 LFB SA Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LFB SA Eptacog Alfa (rFVIIa) Product Portfolio
6.2.5 LFB SA Recent Developments/Updates
6.3 GENERIUM
6.3.1 GENERIUM Company Information
6.3.2 GENERIUM Description and Business Overview
6.3.3 GENERIUM Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GENERIUM Eptacog Alfa (rFVIIa) Product Portfolio
6.3.5 GENERIUM Recent Developments/Updates
6.4 Northland-bio
6.4.1 Northland-bio Company Information
6.4.2 Northland-bio Description and Business Overview
6.4.3 Northland-bio Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Northland-bio Eptacog Alfa (rFVIIa) Product Portfolio
6.4.5 Northland-bio Recent Developments/Updates
6.5 CSL
6.5.1 CSL Company Information
6.5.2 CSL Description and Business Overview
6.5.3 CSL Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CSL Eptacog Alfa (rFVIIa) Product Portfolio
6.5.5 CSL Recent Developments/Updates
6.6 Shire (Takeda)
6.6.1 Shire (Takeda) Company Information
6.6.2 Shire (Takeda) Description and Business Overview
6.6.3 Shire (Takeda) Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shire (Takeda) Eptacog Alfa (rFVIIa) Product Portfolio
6.6.5 Shire (Takeda) Recent Developments/Updates
6.7 Bayer
6.7.1 Bayer Company Information
6.7.2 Bayer Description and Business Overview
6.7.3 Bayer Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer Eptacog Alfa (rFVIIa) Product Portfolio
6.7.5 Bayer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eptacog Alfa (rFVIIa) Industry Chain Analysis
7.2 Eptacog Alfa (rFVIIa) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eptacog Alfa (rFVIIa) Production Mode & Process Analysis
7.4 Eptacog Alfa (rFVIIa) Sales and Marketing
7.4.1 Eptacog Alfa (rFVIIa) Sales Channels
7.4.2 Eptacog Alfa (rFVIIa) Distributors
7.5 Eptacog Alfa (rFVIIa) Customer Analysis
8 Eptacog Alfa (rFVIIa) Market Dynamics
8.1 Eptacog Alfa (rFVIIa) Industry Trends
8.2 Eptacog Alfa (rFVIIa) Market Drivers
8.3 Eptacog Alfa (rFVIIa) Market Challenges
8.4 Eptacog Alfa (rFVIIa) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
LFB SA
Generium
CSL Limited
Shire (Takeda)
Bayer
Northland-bio
Novo Nordisk
List of Tables
 Table 1. Global Eptacog Alfa (rFVIIa) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Eptacog Alfa (rFVIIa) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Eptacog Alfa (rFVIIa) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Eptacog Alfa (rFVIIa) Sales (g) of Key Manufacturers (2020-2025)
 Table 5. Global Eptacog Alfa (rFVIIa) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Eptacog Alfa (rFVIIa) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Eptacog Alfa (rFVIIa) Average Price (US$/mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Eptacog Alfa (rFVIIa), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Eptacog Alfa (rFVIIa), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Eptacog Alfa (rFVIIa), Product Type & Application
 Table 12. Global Key Manufacturers of Eptacog Alfa (rFVIIa), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Eptacog Alfa (rFVIIa) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eptacog Alfa (rFVIIa) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Eptacog Alfa (rFVIIa) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Eptacog Alfa (rFVIIa) Sales by Region (2020-2025) & (g)
 Table 18. Global Eptacog Alfa (rFVIIa) Sales Market Share by Region (2020-2025)
 Table 19. Global Eptacog Alfa (rFVIIa) Sales by Region (2026-2031) & (g)
 Table 20. Global Eptacog Alfa (rFVIIa) Sales Market Share by Region (2026-2031)
 Table 21. Global Eptacog Alfa (rFVIIa) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Region (2020-2025)
 Table 23. Global Eptacog Alfa (rFVIIa) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Region (2026-2031)
 Table 25. North America Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
 Table 27. North America Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
 Table 28. North America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
 Table 32. Europe Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
 Table 33. Europe Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Eptacog Alfa (rFVIIa) Sales by Region (2020-2025) & (g)
 Table 37. Asia Pacific Eptacog Alfa (rFVIIa) Sales by Region (2026-2031) & (g)
 Table 38. Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
 Table 42. Latin America Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
 Table 43. Latin America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
 Table 47. Middle East and Africa Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
 Table 48. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Eptacog Alfa (rFVIIa) Sales (g) by Type (2020-2025)
 Table 51. Global Eptacog Alfa (rFVIIa) Sales (g) by Type (2026-2031)
 Table 52. Global Eptacog Alfa (rFVIIa) Sales Market Share by Type (2020-2025)
 Table 53. Global Eptacog Alfa (rFVIIa) Sales Market Share by Type (2026-2031)
 Table 54. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Type (2020-2025)
 Table 57. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Type (2026-2031)
 Table 58. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Type (2020-2025)
 Table 59. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Type (2026-2031)
 Table 60. Global Eptacog Alfa (rFVIIa) Sales (g) by Application (2020-2025)
 Table 61. Global Eptacog Alfa (rFVIIa) Sales (g) by Application (2026-2031)
 Table 62. Global Eptacog Alfa (rFVIIa) Sales Market Share by Application (2020-2025)
 Table 63. Global Eptacog Alfa (rFVIIa) Sales Market Share by Application (2026-2031)
 Table 64. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Application (2020-2025)
 Table 67. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Application (2026-2031)
 Table 68. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Application (2020-2025)
 Table 69. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Eptacog Alfa (rFVIIa) Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. LFB SA Company Information
 Table 76. LFB SA Description and Business Overview
 Table 77. LFB SA Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 78. LFB SA Eptacog Alfa (rFVIIa) Product
 Table 79. LFB SA Recent Developments/Updates
 Table 80. GENERIUM Company Information
 Table 81. GENERIUM Description and Business Overview
 Table 82. GENERIUM Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 83. GENERIUM Eptacog Alfa (rFVIIa) Product
 Table 84. GENERIUM Recent Developments/Updates
 Table 85. Northland-bio Company Information
 Table 86. Northland-bio Description and Business Overview
 Table 87. Northland-bio Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 88. Northland-bio Eptacog Alfa (rFVIIa) Product
 Table 89. Northland-bio Recent Developments/Updates
 Table 90. CSL Company Information
 Table 91. CSL Description and Business Overview
 Table 92. CSL Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 93. CSL Eptacog Alfa (rFVIIa) Product
 Table 94. CSL Recent Developments/Updates
 Table 95. Shire (Takeda) Company Information
 Table 96. Shire (Takeda) Description and Business Overview
 Table 97. Shire (Takeda) Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 98. Shire (Takeda) Eptacog Alfa (rFVIIa) Product
 Table 99. Shire (Takeda) Recent Developments/Updates
 Table 100. Bayer Company Information
 Table 101. Bayer Description and Business Overview
 Table 102. Bayer Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 103. Bayer Eptacog Alfa (rFVIIa) Product
 Table 104. Bayer Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Eptacog Alfa (rFVIIa) Distributors List
 Table 108. Eptacog Alfa (rFVIIa) Customers List
 Table 109. Eptacog Alfa (rFVIIa) Market Trends
 Table 110. Eptacog Alfa (rFVIIa) Market Drivers
 Table 111. Eptacog Alfa (rFVIIa) Market Challenges
 Table 112. Eptacog Alfa (rFVIIa) Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Eptacog Alfa (rFVIIa)
 Figure 2. Global Eptacog Alfa (rFVIIa) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Eptacog Alfa (rFVIIa) Market Share by Type: 2024 & 2031
 Figure 4. Freeze-dried Preparation Product Picture
 Figure 5. Freeze-dried Powder Product Picture
 Figure 6. Global Eptacog Alfa (rFVIIa) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Eptacog Alfa (rFVIIa) Market Share by Application: 2024 & 2031
 Figure 8. Hemophilia
 Figure 9. Acquired Hemophilia
 Figure 10. Factor VII Deficiency
 Figure 11. Glanzmann Thrombasthenia (GT)
 Figure 12. Global Eptacog Alfa (rFVIIa) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Eptacog Alfa (rFVIIa) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Eptacog Alfa (rFVIIa) Sales (2020-2031) & (g)
 Figure 15. Global Eptacog Alfa (rFVIIa) Average Price (US$/mg) & (2020-2031)
 Figure 16. Eptacog Alfa (rFVIIa) Report Years Considered
 Figure 17. Eptacog Alfa (rFVIIa) Sales Share by Manufacturers in 2024
 Figure 18. Global Eptacog Alfa (rFVIIa) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Eptacog Alfa (rFVIIa) Players: Market Share by Revenue in Eptacog Alfa (rFVIIa) in 2024
 Figure 20. Eptacog Alfa (rFVIIa) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Eptacog Alfa (rFVIIa) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
 Figure 23. North America Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
 Figure 24. United States Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Eptacog Alfa (rFVIIa) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Eptacog Alfa (rFVIIa) Revenue Market Share by Region (2020-2031)
 Figure 35. China Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Eptacog Alfa (rFVIIa) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Eptacog Alfa (rFVIIa) by Type (2020-2031)
 Figure 56. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Eptacog Alfa (rFVIIa) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Eptacog Alfa (rFVIIa) by Application (2020-2031)
 Figure 59. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Application (2020-2031)
 Figure 60. Eptacog Alfa (rFVIIa) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Eptacog Alfa Recombinant Human Coagulation Factor VIIa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Activated Coagulation Factor VII Market Research Report 2025
Global Recombinant Human Coagulation VIIa Market Research Report 2025
Coagulation Factor VIIa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor VII Market Insights Forecast to 2030
Global Eftrenonacog Alfa Market Research Report 2025
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enoxaparin Sodium Market Research Report 2024
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Global Recombinant Coagulation Factors Market Insights Forecast to 2030
Global Human Coagulation Factor IX Market Research Report 2024
Global Human Fibrinogen Market Insights Forecast to 2030
Global Heparin Sodium Injection Market Insights Forecast to 2030
Global Edoxaban Reagent Market Research Report 2024
Global Tranexamic Acid Market Research Report 2025
Fibrinogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Automated Coagulation Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor IV Market Research Report 2024
Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions